Literature DB >> 27927770

Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.

Chiara Briani1, Andrea Visentin2, Alessandro Salvalaggio1, Silvia Imbergamo2, Francesco Piazza2, Mario Cacciavillani3, Marta Campagnolo1, Federica Frezzato2, Gianpietro Semenzato2, Livio Trentin4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27927770      PMCID: PMC5395126          DOI: 10.3324/haematol.2016.153064

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Lenalidomide for bortezomib-resistant multiple myeloma.

Authors:  Chiara Briani; Tamara Berno; Marta Campagnolo; Renato Zambello
Journal:  Nat Rev Clin Oncol       Date:  2010-09       Impact factor: 66.675

Review 2.  Peripheral neuropathies.

Authors:  R Hanewinckel; M A Ikram; P A Van Doorn
Journal:  Handb Clin Neurol       Date:  2016

Review 3.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

Review 4.  The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Kevin S Chen; Eva L Feldman
Journal:  JAMA Neurol       Date:  2015-12       Impact factor: 18.302

5.  Prevalence of monoclonal protein in peripheral neuropathy.

Authors:  J J Kelly; R A Kyle; P C O'Brien; P J Dyck
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

6.  Spectrum of paraneoplastic disease associated with lymphoma.

Authors:  C Briani; R Vitaliani; W Grisold; J Honnorat; F Graus; J C Antoine; G Bertolini; B Giometto
Journal:  Neurology       Date:  2011-02-22       Impact factor: 9.910

7.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

8.  Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.

Authors:  Andrea Visentin; Monica Facco; Federica Frezzato; Monica Castelli; Valentina Trimarco; Veronica Martini; Cristina Gattazzo; Filippo Severin; Giorgia Chiodin; Annalisa Martines; Laura Bonaldi; Ilaria Gianesello; Elisa Pagnin; Elisa Boscaro; Francesco Piazza; Renato Zambello; Gianpietro Semenzato; Livio Trentin
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-20

Review 9.  Paraproteinemic neuropathies.

Authors:  Divisha Raheja; Charles Specht; Zachary Simmons
Journal:  Muscle Nerve       Date:  2014-11-22       Impact factor: 3.217

10.  Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia.

Authors:  Paolo Strati; Joon H Uhm; Timothy J Kaufmann; Chadi Nabhan; Sameer A Parikh; Curtis A Hanson; Kari G Chaffee; Timothy G Call; Tait D Shanafelt
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

View more
  2 in total

1.  Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study.

Authors:  Arina A Tamborska; Bhagteshwar Singh; Sonja E Leonhard; Eva Maria Hodel; Julia Stowe; Taylor Watson-Fargie; Peter M Fernandes; Andreas C Themistocleous; Jacob Roelofs; Kathryn Brennan; Caroline Morrice; Benedict D Michael; Bart C Jacobs; Helen McDonald; Tom Solomon
Journal:  BMJ Neurol Open       Date:  2022-07-12

Review 2.  From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance.

Authors:  Andrea Visentin; Stefano Pravato; Francesca Castellani; Marta Campagnolo; Francesco Angotzi; Chiara Adele Cavarretta; Alessandro Cellini; Valeria Ruocco; Alessandro Salvalaggio; Alessandra Tedeschi; Livio Trentin; Chiara Briani
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.